Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

2.

CEPHEUS SA: a South African survey on the undertreatment of hypercholesterolaemia.

Raal F, Schamroth C, Blom D, Marx J, Rajput M, Haus M, Hussain R, Cassim F, Nortjé M, Vandehoven G, Temmerman AM.

Cardiovasc J Afr. 2011 Sep-Oct;22(5):234-40. doi: 10.5830/CVJA-2011-044.

3.

Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey.

Park JE, Chiang CE, Munawar M, Pham GK, Sukonthasarn A, Aquino AR, Khoo KL, Chan HW.

Eur J Prev Cardiol. 2012 Aug;19(4):781-94. doi: 10.1177/1741826710397100.

PMID:
21450606
4.

Centralized pan-Middle East Survey on the undertreatment of hypercholesterolemia: results from the CEPHEUS study in Arabian Gulf countries.

Arafah M, Al-Hinai AT, Al Mahmeed W, Al-Rasadi K, Al Tamimi O, Al Herz S, Al Anazi F, Al Nemer K, Metwally O, Alkhadra A, Fakhry M, Elghetany H, Medani AR, Yusufali AH, Al Jassim O, Al Hallaq O, Baslaib FO, Alawadhi M, Amin H, Al-Hashmi K, Shehab A.

Angiology. 2014 Nov;65(10):919-26. doi: 10.1177/0003319713512414.

PMID:
24301426
5.

Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey.

Wang KF, Chang CC, Wang KL, Wu CH, Chen LC, Lu TM, Lin SJ, Chiang CE.

J Chin Med Assoc. 2014 Feb;77(2):61-7. doi: 10.1016/j.jcma.2013.10.013.

7.

Centralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): overall findings from eight countries.

Hermans MP, Castro Cabezas M, Strandberg T, Ferrières J, Feely J, Elisaf M, Michel G, Sansoy V.

Curr Med Res Opin. 2010 Feb;26(2):445-54. doi: 10.1185/03007990903500565.

PMID:
20001658
8.

Lipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand survey.

Sukonthasarn A, Homsanit M, Prommete B, Chotinaiwattarakul C, Piamsomboon C, Likittanasombat K.

J Med Assoc Thai. 2011 Dec;94(12):1424-34.

PMID:
22295727
9.
10.

Lipid-lowering treatment practice patterns in korea: comparison with the data obtained from the CEPHEUS Pan-Asian study.

Sung J, Kim SH, Song HR, Chi MH, Park JE.

J Atheroscler Thromb. 2014;21(11):1219-27.

11.
12.

Suboptimal Control of Lipid Levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS).

Chiang CE, Ferrières J, Gotcheva NN, Raal FJ, Shehab A, Sung J, Henriksson KM, Hermans MP.

J Atheroscler Thromb. 2016 May 2;23(5):567-87. doi: 10.5551/jat.31179.

13.

Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.

Rodrigues CJ, Ribeiro HF, Ribeiro AB, Zanella MT, Batista MC.

Metab Syndr Relat Disord. 2012 Jun;10(3):195-201. doi: 10.1089/met.2011.0133.

PMID:
22313142
14.

Achieving low-density lipoprotein cholesterol treatment goals among dyslipidemic individuals in the Levant: the CEntralized Pan-Levant survey on tHE Undertreatment of hypercholeSterolemia (CEPHEUS) study.

Hammoudeh AJ, Echtay A, Ghanem GY, Haddad J; CEPHEUS-Levant survey investigators..

Curr Med Res Opin. 2014 Oct;30(10):1957-65. doi: 10.1185/03007995.2014.929095.

PMID:
24889279
15.

Extent of control of cardiovascular risk factors and adherence to recommended therapies in US multiethnic adults with coronary heart disease: from a 2005-2006 national survey.

Vulic D, Lee BT, Dede J, Lopez VA, Wong ND.

Am J Cardiovasc Drugs. 2010;10(2):109-14. doi: 10.2165/11535240-000000000-00000.

PMID:
20334448
16.

The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre.

Chan RH, Chan PH, Chan KK, Lam SC, Hai JJ, Wong MK, Tam FC, Lam L, Chan CW, Lam YM, Siu DC, Tse HF, Lee SW.

Hong Kong Med J. 2012 Oct;18(5):395-406.

17.

Younger age of escalation of cardiovascular risk factors in Asian Indian subjects.

Gupta R, Misra A, Vikram NK, Kondal D, Gupta SS, Agrawal A, Pandey RM.

BMC Cardiovasc Disord. 2009 Jul 5;9:28. doi: 10.1186/1471-2261-9-28.

18.

Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China).

Wang F, Ye P, Hu D, Min Y, Zhao S, Wang Y, Mu Y, Yan X, Li Z, Wei Y, Li J; DYSIS-China Study Investigators..

Atherosclerosis. 2014 Nov;237(1):99-105. doi: 10.1016/j.atherosclerosis.2014.08.023.

PMID:
25238215
19.

Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study.

Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF.

Diabetologia. 2005 Apr;48(4):649-56.

PMID:
15759110
20.
Items per page

Supplemental Content

Support Center